Basal insulin analog

This page covers all Basal insulin analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.

Targets

Insulin receptor

Marketed (5)

• Insulin Detemir mixed with RAI injection · Montefiore Medical Center · Diabetes
  Insulin detemir provides basal insulin replacement by binding to the insulin receptor, while RAI (radioactive iodine) component is unclear in this context as RAI is typically used for thyroid ablation, not diabetes management.
• Tresiba® · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Diabetes
  Tresiba is a long-acting basal insulin analog that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in peripheral tissues.
• Detemir insulin · The University of Texas Health Science Center, Houston · Diabetes
  Detemir insulin is a long-acting basal insulin that binds to the insulin receptor to lower blood glucose by promoting glucose uptake and storage in cells.
• Insulin Lispro Protamine Suspension · Eli Lilly and Company · Diabetes
  Insulin lispro protamine suspension is a long-acting basal insulin that binds to insulin receptors on muscle and fat cells to promote glucose uptake and storage, lowering blood glucose levels.
• Basal Insulin Analog · Eli Lilly and Company · Diabetes
  Basal insulin analogs mimic the body's natural background insulin secretion by binding to insulin receptors and promoting glucose uptake into cells.

Phase 3 pipeline (2)

• LY2963016 · Eli Lilly and Company · Diabetes
  LY2963016 is a long-acting basal insulin analog that binds to the insulin receptor to regulate blood glucose by promoting glucose uptake and storage.
• LY2605541 · Eli Lilly and Company · Diabetes
  LY2605541 is a long-acting basal insulin analog that binds to the insulin receptor to lower blood glucose levels in diabetes.